Cholinesterases (especially acetylcholinesterase) are important factors in neurotransmission across synaptic gaps, and the inhibition of these may enhance the cognitive functioning in patients with Alzheimer’s disease [73]. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.